Skip to main content
logo
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
10.03
-0.10 (-0.99%)
At close: Jul 24, 2026, 4:00 PM EDT
10.00
-0.03 (-0.30%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Artiva Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.2533.494.932
Revenue Growth (YoY)
---99.25%579.21%146.30%-
Gross Profit
--0.2533.494.932
Selling, General & Admin
20.2720.2717.2113.9120.7812.86
Research & Development
71.869.5450.3350.2543.9842.41
Total Operating Expenses
92.0789.8167.5364.1664.7655.27
Operating Income
-92.07-89.81-67.28-30.67-59.83-53.27
Interest Income
5.015.965.352.541.29-
Other Non-Operating Income (Expense)
-0.01-0.01-3.44-0.51-0.218.55
Total Non-Operating Income (Expense)
55.951.912.021.0918.55
Pretax Income
-87.07-83.87-65.37-28.65-58.74-34.72
Provision for Income Taxes
----0.07-0.05-
Net Income
-87.07-83.87-65.37-28.72-58.79-34.72
Net Income to Common
-87.07-83.87-65.37-28.72-58.79-34.72
Net Income Growth
------
Shares Outstanding (Basic)
252411111
Shares Outstanding (Diluted)
252411111
Shares Change (YoY)
43.36%117.11%1302.54%4.70%11.80%8.60%
EPS (Basic)
-3.54-3.43-5.81-35.7876.67-104.74
EPS (Diluted)
-3.54-3.43-5.81-35.7876.67-104.74
EPS Growth
------
Free Cash Flow
-80.18-79.34-55.67-50.69-57.13-17.03
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.27-3.25-4.94-63.14-74.51-24.83
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---26805.60%-91.58%-1213.32%-2660.94%
Profit Margin
---26045.00%-85.75%-1192.21%-1734.22%
FCF Margin
---22180.90%-151.34%-1158.55%-850.55%
EBITDA
-89.43-87.21-64.85-28.41-58.67-53.02
EBITDA Margin
---25837.10%-84.81%-1189.84%-2648.55%
EBIT
-92.07-89.81-67.28-30.67-59.83-53.27
EBIT Margin
---26805.60%-91.58%-1213.32%-2660.94%
Effective Tax Rate
-0.00%0.00%0.25%0.09%0.00%
SEC Filings: 10-K · 10-Q